A Case of Hemangiopericytoma İnvolved the Lungs
[AKCİĞERLERE METASTAZ YAPMIŞ BİR HEMANGIOPERICYTOMA OLGUSU]


DOI:
https://doi.org/10.58600/eurjther.19910202-541Keywords:
Hemangiopericytoma, pulmonar metastasizingAbstract
Hemangiopericytomas are rare tumors. They are originated from pericytes of the small vessels and can appear anywhere in the body. it is difficult to determine whether they are malignant or not from the histological picture. The tumor's location is highly influancial on the metastasizing rate which usually varies from 50 to 80%. Loca! recurrences approximately 50 percent of the cases. Since radio and chemotherapy are less effective, hemangiopericytoma is preferably surgically treated. in this article, an interesting hemangiopericytoma case is presented. A patient with primary lesion in his left arm, with pulmonary metastasizing hemangiopericytoma
treated with surgical exision and chemotherapy and is still alive ten years after the first diagnosis is reported.
Metrics
References
Stout AP., Murray. Hemangiopericytoma: A vascular tumor featuring Zimmermann's pericytes. Ann Surg 116:26, 1942.
Hansen CP., Francis, Bertelsen S.: Primary Hemangiopericytoma of lung. Scand J Thor Crdiovsc Surg 24:89-92, 1990.
Enzinger FM., Smith BH.: Hemangiopericytoma. Hum Pathol 7:61, 1976.
Cook C., Kakos GS., Robert S.: Hemangiopericytoma. A case report and rationale for agressive terapy. Çançer 24:1830, 1974.
Feldman F., Seaman WB.: Primary thoracic Hemangiopericytoma. Radiology 82:998-1008, 1964.
Backwinkel KD., Didams JK.: Hemangiopericytoma. Report of case and comprehensive review of the literature. Cancer 25:896-901, 1970.
Heckmayer M., Gatsemeier U., Radenbach D.: Pulmonary metastasizing Hemangiopericytoma. Am J Clin Oncol (CCT) 11 (6):636-642, 1988.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.